2018
Lamendella R, Wright JR, Hackman J, McLimans C, Toole DR, Bernard Rubio W, Drucker R, Wong HT, Sabey K, Hegarty JP, et al. 2018. Antibiotic Treatments for Infection Are Associated with Distinct Bacterial and Fungal Community Structures. mSphere. 3. doi:10.1128/mSphere.00572-17.
Sandoval PJ, Zorn KM, Clark AM, Ekins S, Wright SH. 2018. Assessment of Substrate-Dependent Ligand Interactions at the Organic Cation Transporter OCT2 Using Six Model Substrates. Mol Pharmacol. 94:1057–1068. doi:10.1124/mol.117.111443.
Lichauco K, Lee MS, Kuhns MS. 2018. Bonds Voyage! A Dissociative Model of TCR-CD3 Triggering Is Proposed. Immunity. 49:786–788. doi:10.1016/j.immuni.2018.11.008.
Sharma AK, Krzeminski J, Weissig V, Hegarty JP, Stewart DB. 2018. Cationic amphiphilic bolaamphiphile-based delivery of antisense oligonucleotides provides a potentially microbiome sparing treatment for C. difficile. J Antibiot (Tokyo). 71:713–721. doi:10.1038/s41429-018-0056-9.
Martinez JA, Yang J, Wertheim BC, Roe DJ, Schriewer A, Lance P, Alberts DS, Hammock BD, Thompson PA. 2018. Celecoxib use and circulating oxylipins in a colon polyp prevention trial. PLoS One. 13:e0196398. doi:10.1371/journal.pone.0196398.
Ross MD, Biswas Roy S, Patil PD, Huang JL, Thawani N, Drosten R, Panchabhai TS. 2018. Coexistent Non-Small Cell Carcinoma and Small Cell Carcinoma in a Patient Presenting with Hyponatremia. Case Rep Pulmonol. 2018:1718326. doi:10.1155/2018/1718326.
Padi M, Quackenbush J. 2018. Detecting phenotype-driven transitions in regulatory network structure. NPJ Syst Biol Appl. 4:16. doi:10.1038/s41540-018-0052-5.
Kulaylat AS, Buonomo EL, Scully KW, Hollenbeak CS, Cook H, Petri WA, Stewart DB. 2018. Development and Validation of a Prediction Model for Mortality and Adverse Outcomes Among Patients With Peripheral Eosinopenia on Admission for Clostridium difficile Infection. JAMA Surg. 153:1127–1133. doi:10.1001/jamasurg.2018.3174.
Remeniuk B, King T, Sukhtankar D, Nippert A, Li N, Li F, Cheng K, Rice KC, Porreca F. 2018. Disease modifying actions of interleukin-6 blockade in a rat model of bone cancer pain. Pain. 159:684–698. doi:10.1097/j.pain.0000000000001139.
Akam EA, Utterback RD, Marcero JR, Dailey HA, Tomat E. 2018. Disulfide-masked iron prochelators: Effects on cell death, proliferation, and hemoglobin production. J Inorg Biochem. 180:186–193. doi:10.1016/j.jinorgbio.2017.12.016.
Rice PFS, Ehrichs KG, Jones MS, Chen H, Hsu C-H, Abril ER, Nagle RB, Besselsen DG, Barton JK, Ignatenko NA. 2018. Does Mutated Oncogene Attenuate the Effect of Sulindac in Colon Cancer Chemoprevention?. Cancer Prev Res (Phila). 11:16–26. doi:10.1158/1940-6207.CAPR-17-0230.
Centuori SM, Gomes CJ, Kim SS, Putnam CW, Larsen BT, Garland LL, Mount DW, Martinez JD. 2018. Double-negative (CD27IgD) B cells are expanded in NSCLC and inversely correlate with affinity-matured B cell populations. J Transl Med. 16:30. doi:10.1186/s12967-018-1404-z.
Kumar GS, Clarkson MW, Kunze MBA, Granata D, Wand AJ, Lindorff-Larsen K, Page R, Peti W. 2018. Dynamic activation and regulation of the mitogen-activated protein kinase p38. Proc Natl Acad Sci U S A. 115:4655–4660. doi:10.1073/pnas.1721441115.
Thorne CA, Chen IW, Sanman LE, Cobb MH, Wu LF, Altschuler SJ. 2018. Enteroid Monolayers Reveal an Autonomous WNT and BMP Circuit Controlling Intestinal Epithelial Growth and Organization. Dev Cell. 44:624–633.e4. doi:10.1016/j.devcel.2018.01.024.
Patwardhan A, Matika R, Gordon J, Singer B, Salloum M, Ibrahim M. 2018. Exploring the Role of Chronic Pain Clinics: Potential for Opioid Reduction. Pain Physician. 21:E603-E610.
Jacobs ET, Gupta S, Baron JA, Cross AJ, Lieberman DA, Murphy G, Martinez ME. 2018. Family history of colorectal cancer in first-degree relatives and metachronous colorectal adenoma. Am J Gastroenterol. 113:899–905. doi:10.1038/s41395-018-0007-x.
Witte RS, Karunakaran C, Zuniga AN, Schmitz H, Arif H. 2018. Frontiers of cancer imaging and guided therapy using ultrasound, light, and microwaves. Clin Exp Metastasis. 35:413–418. doi:10.1007/s10585-018-9923-9.
Toth EL, Li H, Dzierlenga AL, Clarke JD, Vildhede A, Goedken M, Cherrington NJ. 2018. Gene-by-Environment Interaction of Bcrp and Methionine- and Choline-Deficient Diet-Induced Nonalcoholic Steatohepatitis Alters SN-38 Disposition. Drug Metab Dispos. 46:1478–1486. doi:10.1124/dmd.118.082081.
Bell ML, Whitehead AL, Julious SA. 2018. Guidance for using pilot studies to inform the design of intervention trials with continuous outcomes. Clin Epidemiol. 10:153–157. doi:10.2147/CLEP.S146397.
Chakrabarti S, Paek AL, Reyes J, Lasick KA, Lahav G, Michor F. 2018. Hidden heterogeneity and circadian-controlled cell fate inferred from single cell lineages. Nat Commun. 9:5372. doi:10.1038/s41467-018-07788-5.
Vanderbilt DB, Ho Q-A, Goyal U, Bell RC, Klein RR, Yi SK. 2018. HPV-related nasopharyngeal and cervical cancer in a married couple in North America. Pract Radiat Oncol. 8:e1-e5. doi:10.1016/j.prro.2017.09.003.
Casillas AL, Toth RK, Sainz AG, Singh N, Desai AA, Kraft AS, Warfel NA. 2018. Hypoxia-Inducible PIM Kinase Expression Promotes Resistance to Antiangiogenic Agents. Clin Cancer Res. 24:169–180. doi:10.1158/1078-0432.CCR-17-1318.
Liptak C, Mahmoud MM, Eckenroth BE, Moreno MV, East K, Alnajjar KS, Huang J, Towle-Weicksel JB, Doublié S, Loria JP, et al. 2018. I260Q DNA polymerase β highlights precatalytic conformational rearrangements critical for fidelity. Nucleic Acids Res. 46:10740–10756. doi:10.1093/nar/gky825.
Chipollini J, Azizi M, Peyton CC, Tang DH, Dhillon J, Spiess PE. 2018. Implications of Programmed Death Ligand-1 Positivity in Non-Clear Cell Renal Cell Carcinoma. J Kidney Cancer VHL. 5:6–13. doi:10.15586/jkcvhl.2018.107.
Fang K, Dong G, Wang H, He S, Wu S, Wang W, Sheng C. 2018. Improving the Potency of Cancer Immunotherapy by Dual Targeting of IDO1 and DNA. ChemMedChem. 13:30–36. doi:10.1002/cmdc.201700666.
Pagination
- First page
- …
- 21
- 22
- 23
- …
- Last page